1. Home
  2. GAIN vs DRTS Comparison

GAIN vs DRTS Comparison

Compare GAIN & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gladstone Investment Corporation Business Development Company

GAIN

Gladstone Investment Corporation Business Development Company

HOLD

Current Price

$15.91

Market Cap

653.5M

Sector

Finance

ML Signal

HOLD

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$10.03

Market Cap

641.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GAIN
DRTS
Founded
2005
2015
Country
United States
Israel
Employees
70
121
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
653.5M
641.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GAIN
DRTS
Price
$15.91
$10.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$14.75
$8.67
AVG Volume (30 Days)
420.2K
816.8K
Earning Date
05-12-2026
05-18-2026
Dividend Yield
9.19%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.07
N/A
Revenue Next Year
$7.32
$699.98
P/E Ratio
$4.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.14
$2.81
52 Week High
$17.14
$11.62

Technical Indicators

Market Signals
Indicator
GAIN
DRTS
Relative Strength Index (RSI) 47.27 58.03
Support Level $15.78 $6.59
Resistance Level $17.04 N/A
Average True Range (ATR) 0.63 0.89
MACD -0.13 0.13
Stochastic Oscillator 51.29 64.26

Price Performance

Historical Comparison
GAIN
DRTS

About GAIN Gladstone Investment Corporation Business Development Company

Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to achieve and grow current income by investing in debt securities of established businesses; provide the stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Share on Social Networks: